News

UMass Chan Medical School researchers are embarking on a clinical trial of an mRNA vaccine by Moderna against the Epstein-Barr virus, a common cause of infectious mononucleosis. Katherine Luzuriaga, MD, is principal investigator for the study at UMass Chan.

Worcester Business Journal readers have chosen the UMass Cancer Walk and Run as the best nonprofit fundraiser event in Central Massachusetts.

Ann Moormann, PhD, MPH, is recognized for outstanding contributions to the development of science and career advancement of scientists in Africa.

UMass Medical School researchers are about to start enrolling adolescents ages 12 through 17 in a clinical trial to test the COVID-19 mRNA vaccine made by Moderna. (Originally published on Jan. 26, 2021)

Lyme PrEP, a seasonal shot to prevent Lyme disease developed by MassBiologics at UMass Medical School, has begun enrolling volunteers to evaluate the safety and pharmacology of the treatment. (Originally published on Fed. 24, 2021)

Results of a clinical trial led by Jonathan M. Gerber, MD, suggest that early use of convalescent plasma treatment for COVID-19 helps avoid hospitalization.

Zaida Ramirez-Ortiz, PhD’11, received a 2021 Lupus Innovation Award by the Lupus Research Alliance for her work probing an underlying mechanism of lupus.

UMass Chan Medical School researchers are starting a Phase II clinical trial of Moderna COVID-19 mRNA vaccine boosters in adults. The study comes as scientists chase the continuous emergence of new SARS-CoV-2 virus variants. 

The UMass Cancer Center Pilot Project Program has awarded seed grants to five UMass Chan Medical School research projects to enable investigators to gather pilot data for external cancer-focused funding.

In a new Voices of UMass Chan podcast, two UMass Chan Medical School researchers who have been tracking vaccine acceptance since the COVID-19 pandemic, share reliable advice based on their findings.